logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial

Bonnet MMB, Bhatt NB, Baudin E, Silva C, Michon C,  et al.
2013-04-01 • Lancet Infectious Diseases
2013-04-01 • Lancet Infectious Diseases
BACKGROUND
In countries with a high incidence of HIV and tuberculosis co-infection, nevirapine and efavirenz are widely used as antiretroviral therapy but both interact with antitube...
Journal Article
|
Research

Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome

Bonnet MMB, Baudin E, Jani IV, Nunes E, Verhoustraeten F,  et al.
2013-12-18 • PLOS One
2013-12-18 • PLOS One
OBJECTIVES AND DESIGN
We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosi...
Journal Article
|
Pre-Print

Early assessment of antiretroviral efficacy is critical to prevent the emergence of resistance mutations in HIV-tuberculosis coinfected patients: a substudy of the CARINEMO-ANRS12146 trial

Baudin E, Bhatt NB, Rouzioux C, Serafini M, Molfino L,  et al.
2019-02-08 • F1000Research
2019-02-08 • F1000Research
BACKGROUND
In the CARINEMO ANRS 12146 clinical trial, HIV-tuberculosis co-infected patients in Mozambique were randomized to nevirapine (NVP) or to efavirenz (EFV)-based antiretrovir...
Journal Article
|
Research

Sustainable HIV treatment in Africa through viral-load-Informed differentiated care

Phillips AN, Shroufi A, Vojnov L, Cohn J, Roberts TR,  et al.
2015-12-01 • Nature
2015-12-01 • Nature
There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical ...
Journal Article
|
Research

Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients

Bhatt NB, Gudo ES, Sema C, Bila D, Di Mattei P,  et al.
2009-12-01 • International Journal of STD and AIDS
2009-12-01 • International Journal of STD and AIDS
Seven hundred and four HIV-1/2-positive, antiretroviral therapy (ART) naïve patients were screened for HTLV-1 infection. Antibodies to HTLV-1 were found in 32/704 (4.5%) of the patients....
Journal Article
|
Commentary

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring

Peter T, Ellenberger D, Kim AA, Boeras D, Messele T,  et al.
2016-10-20 • Lancet Infectious Diseases
2016-10-20 • Lancet Infectious Diseases
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the ...